Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
about
[EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance].Effectiveness of Nivolumab versus Docetaxel as Second-Line Treatment in Non-Small Cell Lung Cancer Patients in Clinical Practice.Immunotherapy in the Asiatic population: any differences from Caucasian population?Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse eventsNivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safetyAssociation of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
P2860
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@ast
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@en
type
label
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@ast
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@en
prefLabel
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@ast
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Efficacy and safety of nivolum ...... us non-small cell lung cancer.
@en
P2093
Hideo Saka
Hiroshi Isobe
Hiroshi Nokihara
Hiroshi Sakai
Hiroshi Tanaka
Kazuhiko Nakagawa
Koichi Goto
Koichi Minato
Koji Takeda
Makoto Maemondo
P2860
P304
P356
10.1111/CAS.13225
P50
P577
2017-03-07T00:00:00Z